Private
First responders and healthcare workers stand to benefit from a new partnership between the Biomedical Advanced Research and Development Authority (BARDA) and Evidation Health, which are sifting through data from wearable devices to create an early warning algorithm for COVID-19 symptoms.
This... Read More »
Hollingsworth & Vose has secured a $2.2 million Department of Defense (DoD) contract to increase domestic ventilator and respirator production.
The effort involves producing 27.5 million N95 filters, and 3.1 million N95 respirators per monthly, beginning in August. The endeavor is in support of... Read More »
Scientists and engineers at Texas A&M University are developing a device that can rapidly identify antibodies that can neutralize infection by SARS-CoV-2, the virus that causes COVID-19.
"The difficulty of developing therapeutics and vaccines against emerging viral threats can also be obviously... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) is working with Quidel Corp. to develop to detect COVID-19 and three additional respiratory viruses.
The two will work together to develop a rapid multi-analyte diagnostic test for use on the Sofia 2 assay system to detect the... Read More »
The latest addition to the Biomedical Advanced Research and Development Authority’s (BARDA) COVID-19 countermeasure portfolio is an automated total antibody test being developed in partnership with Siemens Healthineers.
The serological, lab-based test proposes to detect two items in human... Read More »
Pentagon officials said FLIR Systems has installed its EST screening system at the Visitor Center in Washington, D.C., to screen visitors for potential COVID-19 symptoms.
“For more than 40 years, FLIR has provided advanced thermal imaging technology to America’s military — on its aircraft,... Read More »
BAE Systems said it has completed the initial test of its APKWS laser-guided rockets from a tactical configuration ground-based weapon system.
“Our customers see the value in low-cost, precision-strike capabilities that reduce the risk of collateral damage, and they want the flexibility to... Read More »
A partnership between the Biomedical Advanced Research and Development Authority (BARDA) and biotechnology company Genentech will yield a phase 2 clinical trial to evaluate two investigational drugs for the treatment of severe COVID-19 cases: anti-ST2 and IL-22-Fc.
The drugs will be tested on... Read More »
Defense Advanced Research Projects Agency (DARPA) officials said a pair of California-based firms have been selected to participate in its Gamma Ray Inspection Technology (GRIT) program to aid medical applications.
Lumitron Technologies and RadiaBeam Technologies have initiated efforts to... Read More »
Chimeron Bio and George Mason University's National Center for Biodefense and Infectious Diseases (NCBID) are teaming up to develop a COVID-19 vaccine.
The vaccine development will be based on Chimeron Bio's ChaESARTM self-amplifying RNA technology. Plus, it will integrate Mason's complimenting... Read More »
Operation Warp Speed, the White House-created program to speed up COVID-19 vaccine candidate development and manufacturing domestically, will benefit from a $628 million expansion of an existing public-private partnership with Emergent BioSolutions Inc., the U.S. Department of Health and Human... Read More »
A phase 3 clinical trial that will utilize a mix of Actemra/RoActemra and remdesivir on hospitalized COVID-19 patients with severe pneumonia is expected to begin in June, as part of a collaboration between Roche and Gilead Sciences, Inc.
That trial, REMDACTA, will be double-blind, randomized,... Read More »
GlaxoSmithKline (GSK) said it will manufacture 1 billion doses of its pandemic vaccine adjuvant system in 2021 to support the development of multiple adjuvanted COVID-19 vaccine candidates.
The pharmaceutical company says its pandemic adjuvant technology could make a significant contribution... Read More »
A new reference panel being offered by the U.S. Food and Drug Administration (FDA) proposes an additional, independent validation step to guarantee the quality of COVID-19 diagnostic tests.
Since COVID-19 reached U.S. shores earlier this year, many tests have arisen to detect its viral cause:... Read More »
Recent findings from a NORC at the University of Chicago study have determined if a COVID-19 vaccine becomes available, 49 percent of respondents said they plan to get vaccinated.
The nationwide poll was conducted May 14-18, 2020, via the AmeriSpeak Panel - the probability-based panel of NORC at... Read More »
Merck announced a series of actions against COVID-19 this week, joining the fight against the global pandemic through two agreements that further potential vaccines against its viral source, SARS-CoV-2, and a research collaboration intended to create a novel antiviral candidate.
“With our... Read More »
A COVID-19 vaccine candidate created by Novavax, Inc. and supported by the Coalition for Epidemic Preparedness Innovations (CEPI) began clinical trials this week, with the enrollment of participants in a Phase 1/2 study.
The vaccine in question is called NVX-CoV2373, a stable, prefusion protein... Read More »
Social media companies need to step up and use the technology they already have to limit extremist groups from spreading misinformation and conspiracy theories online, experts said Wednesday during a U.S. House Homeland Security Committee virtual forum on extremism during the COVID-19 pandemic.... Read More »
A preliminary report on data from the Adaptive COVID-19 Treatment Trial, published in the New England Journal of Medicine last week, showed positive potential for remdesivir as a treatment for COVID-19.
The randomized, controlled trial, sponsored by the National Institute of Allergy and... Read More »
Through its COVID-Local site, the Nuclear Threat Initiative (NTI) has released a guide of new metrics meant to guide local leaders and state officials in safely reopening the United States.
The site now includes interactive graphics and downloadable PDFs, meant to aid assessment of existing... Read More »
U.S. Food and Drug Administration (FDA) regulators have moved against dozens of supposed COVID-19 antibody tests that have never been shown to work, publishing a list of those that failed to file applications or have already pulled their products voluntarily.
There are 28 on that list so far,... Read More »
Two agencies are espousing the benefits of the Innovation Summit for Preparedness and Resilience (InSPIRE), which is dedicated to fostering policy and technology innovation for preparedness and resilience.
The summit was hosted by the Department of Homeland Security (DHS) Science and Technology... Read More »
AstraZeneca has reached first agreements for at least 400 million doses of a potential COVID-19 vaccine developed by the University of Oxford, including 300 million for the United States.
First shipments will begin rolling out to the U.K. in September, then the United States in October. The... Read More »
Lockheed Martin is adjusting work schedules, maintaining specialized employee skill sets, and accelerating payments to vulnerable suppliers in response to F-35 supplier delays due to COVID-19.
"These are challenging times, but managing tough challenges is when the F-35 program performs at its... Read More »
Mount Sinai Health System and Renalytix AI have formed Kantaro Biosciences, LLC, as a means of developing, producing, and distributing a COVID-19 testing kit based on Mount Sinai’s high-performance serologic assay for antibodies.
The test kits hunt for SARS-CoV-2 antibodies and are usable in... Read More »
National Fraternal Order of Police (FOP) personnel said the organization has united with AT&T to educate officers nationwide regarding the benefits of FirstNet, the public safety communications platform.
The initiative involves providing insight on the impact FirstNet can have on public safety... Read More »
A pair of Lawrence Livermore National Laboratory (LLNL) researchers are part of a three-institution team funded by the Defense Threat Reduction Agency (DTRA) to further develop a tularemia vaccine.
Nick Fischer and Amy Rasley will collaborate with University of New Mexico and Tulane National... Read More »
National Institutes of Health (NIH) Director Francis Collins co-wrote an article in the Journal of the American Medical Association (JAMA) that a swift, coordinated effort across many sectors of society is necessary to respond to the COVID-19 pandemic.
The article – co-written by Collins and... Read More »
With an underwritten public offering of $1.25 billion in shares of common stock, Moderna, Inc. hopes to entice buyers to raise funds for the manufacturing of mRNA-1273, the company’s vaccine candidate for use on SARS-CoV-2 -- the virus responsible for COVID-19.
Additionally, underwriters will... Read More »
In an effort to counter potential medical shortages, the United States federal government has awarded $354 million to the Phlow Corporation, with an eye on advanced manufacturing of essential medicines.
In all, that contract could stretch up to $812 million, thanks to a four-year base award of... Read More »
The Association of State and Territorial Health Officials (ASTHO) and National Coalition of STD Directors (NCSD) said the agencies have trained over 10,000 individuals nationwide in COVID-19 contact tracing.
The effort seeks to support ongoing state and local public health agencies in preparing... Read More »
The Trump administration appointed last week Dr. Moncef Slaoui and U.S. Army General Gustave F. Perna to lead the advancement of Operation Warp Speed, a program to accelerate the development, manufacturing, and distribution of COVID-19 medical countermeasures.
Slaoui, a former Chairman of both... Read More »
Research conducted last month by scientists from the National Institutes of Health and the University of Oxford showed promise for the investigational SARS-CoV-2 vaccine, ChAdOx1 nCoV-19, at least when used on rhesus macaques.
The vaccine, which was created by the University of Oxford Jenner... Read More »
The leaders of Costa Rica and Chile, working with the World Health Organization (WHO), are spearheading an effort to create a technology platform that aims to lift access barriers to effective vaccines, medicines, and other health products against COVID-19.
“Our proposal relies on... Read More »
Security screening firm Smiths Detection has introduced an ultraviolet (UVC) light kit it maintains is capable of destroying up to 99.9 percent of microorganisms present at airport security checkpoints.
Smiths Detection UVC kits automatically disinfect baggage trays as they are being transported... Read More »
